Last10K.com

Actinium Pharmaceuticals, Inc. (ATNM) SEC Filing 10-Q Quarterly report for the period ending Sunday, June 30, 2019

Actinium Pharmaceuticals, Inc.

CIK: 1388320 Ticker: ATNM
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2019
Aug. 09, 2019
Document and Entity Information [Abstract]  
Entity Registrant NameActinium Pharmaceuticals, Inc. 
Entity Central Index Key0001388320 
Amendment Flagfalse 
Current Fiscal Year End Date--12-31 
Document Type10-Q 
Document Period End DateJun. 30, 2019 
Document Fiscal Period FocusQ2 
Document Fiscal Year Focus2019 
Entity Current Reporting StatusYes 
Entity Filer CategoryAccelerated Filer 
Entity Ex Transition Periodfalse 
Entity Shell Companyfalse 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Common Stock, Shares Outstanding 162,425,600
Entity File Number000-52446 
Entity Interactive Data CurrentYes 
Entity Incorporation State Country CodeDE 

View differences made from one quarter to another to evaluate Actinium Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Actinium Pharmaceuticals, Inc..

Continue

Assess how Actinium Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Actinium Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Actinium Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits

Ticker: ATNM
CIK: 1388320
Form Type: 10-Q Quarterly Report
Accession Number: 0001213900-19-015171
Submitted to the SEC: Fri Aug 09 2019 5:02:04 PM EST
Accepted by the SEC: Fri Aug 09 2019
Period: Sunday, June 30, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/atnm/0001213900-19-015171.htm